Intel came under pressure after Elon Musk confirmed discussions with Taiwan Semiconductor Manufacturing about a potential role in the Terafab AI manufacturing project.
The concern is straightforward: Intel had previously been identified as a Terafab partner, with Musk saying the project would use Intel’s upcoming 14A manufacturing process. Adding TSMC creates uncertainty around how much manufacturing share Intel could ultimately receive.
The supplied source says Intel shares moved lower after the TSMC discussions became public, following a roughly 30% gain since the beginning of September.
The project itself remains years away from operation and is exceptionally large. The source describes Terafab as targeting one terawatt of compute per year, or 1,000 gigawatts.
At that scale, a multi-supplier strategy would be logical. A project this ambitious could require different foundries, packaging capabilities and chip architectures rather than relying on one manufacturing partner.
Intel also has a separate near-term driver. The source says enterprise and personal agentic workloads are expected to keep demand for CPUs strong enough to create supply constraints and support higher average selling prices.
For investors, the important distinction is between headline risk and fundamental displacement. TSMC involvement may reduce Intel’s share of the opportunity, but it does not necessarily eliminate Intel from the project.
BTI’s bottom line: the TSMC news weakens the cleanest version of the Intel-Terafab bull case, but it does not yet invalidate it. Investors should watch for formal project roles, process-node commitments and concrete production timelines before assuming a winner-take-all outcome.